BUY Glenmark Pharmaceuticals — Siddharth Rai Mangala, 11 Aug 2026

bySiddharth Rai MangalaHorizon: NA (inferred Swing (≤2wk))11 Aug 2026via Zee Business (Live)

Entry₹2,285Inferred

Target₹2,340

Stop loss₹2,265-0.88% risk

Exit₹2,34014 Aug 2026, 10:30 am

Target hit+2.41%0.00%upside left

Follow Siddharth Rai Mangala for new calls(31% target hit, 91 closed calls)Get alerts Watch GLENMARK for new buy/sell callsGet alerts See 116 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 14 Aug 2026

7 supporting5 neutral2 opposing

Supports the BUY call (7)

3 advisors have active intraday BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·14 Aug · today

2 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·12 Aug · 2d ago

Glenmark Pharma Q1 Revenue Beats Estimates, EBITDA Margins Seen Rising

NewsGoogle News·4 Aug · 1w ago

Glenmark Pharma's India-US Growth Story Intact, Says Motilal Oswal, Maintaining 'Buy' — Check Target Price

NewsNdtv-Profit·4 Aug · 1w ago

Glenmark Pharma Q1 profit jumps over 10-fold as India, North America businesses power growth

NewsCnbc-Tv18·31 Jul · 2w ago

Neutral / worth noting (5)

Glenmark USA has agreed to a settlement of $15.28 million to resolve antitrust and consumer protection lawsuits related to price-fixing allegations. The company denies all allegations and states the s

BSE · Company Update·11 Aug · 2d ago

Glenmark Pharma Q1 FY27 Results and Brokerage Outlook

NewsGoogle News·4 Aug · 1w ago

Stock Picks Today: Glenmark Pharma, United Spirits, Kansai Nerolac, UPL, Exide And More On Brokerages' Radar

NewsNdtv-Profit·4 Aug · 1w ago

Glenmark Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·31 Jul · 2w ago

The Board of Directors has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026

BSE · Board Meeting·31 Jul · 2w ago

Weighs against the BUY call (2)

Glenmark Pharma US arm agrees to $15.28 million settlement with Humana over antitrust lawsuits

NewsCnbc-Tv18·12 Aug · 2d ago

1 other SEBI-registered advisor has an active swing SELL call on this stock, issued in the last 14 days

Advisor consensus · same horizon·7 Aug · 6d ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.